Observational studyBMC oral health2026
Evaluation of 5T high-field MRI for identification of mandibular third molar and inferior alveolar nerve structures: a study compared with 3T MRI and CBCT.
Observational study in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThis pilot study is the first to investigate the effect of 5T magnetic resonance 3D imaging on the identification of mandibular third molar (MTM) and inferior alveolar nerve (IAN) and to compare it with 3T MRI and CBCT. MATERIALS AND
methodsSixteen healthy volunteers participated in the study (The clinical trial registration number is “ChiCTR2300074886”. Trial Registration date is 2023.08.18). Four 3D imaging sequences, T1-weighted 3D fast spoiled gradient echo (T1 QUICK3D), T1 QUICK3D with fat suppression (T1 QUICK3D FS), T1-weighted 3D modulated flip angle technique in refocused imaging with extended echo train (T1 MX3D) and T2-weighted MX3D with fat suppression (T2 MX3D FS) were used for comparison. Two blinded independent observers performed qualitative comparisons between 5T MRI, 3T MRI and CBCT using a 5-point Likert scale, and quantitative comparisons between 5T MRI and 3T MRI using signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR). The scan times of 5T MRI and 3T MRI were also compared.
resultsThe inter-observer and intra-observer agreements of the assessments were moderate to excellent (Kappa = 0.590-1.000, ICCs = 0.645-1.000, p < 0.05). All qualitative assessment metrics showed that 5T MRI was significantly better than 3T MRI (p < 0.05). Both SNR and CNR were significantly higher with 5T compared to 3T (p < 0.001). The T1 MX3D sequence on 5T was comparable to CBCT for MTM and IAN imaging. The T1 MX3D had the best contrast for MTM imaging, and the T1 QUICK3D FS sequence was best suited for imaging the IAN.
conclusionsThis study preliminarily demonstrates that 5T MRI can provide high-resolution 3D imaging of the MTM and IAN in vivo, and can be a powerful complement to existing detection techniques in the imaging evaluation of extracting third molars.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.